ImpriMed
ImpriMed specializes in AI-driven personalized prediction profiles for canine and feline lymphoma and leukemia treatment, offering comprehensive diagnostic services and collaborating with over 250 hospitals to collect real-world clinical evidence.
Services
ImpriMed specializes in providing personalized prediction profiles for canine and feline lymphoma and leukemia treatment. The company uses AI-driven drug response predictions to help veterinarians make informed treatment decisions. Key services include Flow Cytometry, PCR for Antigen Receptor Rearrangement (PARR), and a Personalized Prediction Profile that includes predictions for 13 commonly used anticancer drugs. ImpriMed also offers a suite of customizable CRO services for drug candidates targeting human acute myeloid leukemia, non-Hodgkin lymphoma, or blood cancers in companion animals.
Diagnostic Tools
ImpriMed provides a comprehensive diagnostic service that includes cutting-edge techniques such as Flow Cytometry and PARR (PCR for Antigen Receptor Rearrangement). The company has also developed a proprietary transport medium to keep cancer cells healthy during shipping. These diagnostic tools support their AI-driven drug response predictions, ensuring accurate and reliable results for veterinarians.
Collaborations and Clinical Evidence
ImpriMed collaborates with over 250 hospitals to collect real-world clinical evidence and has processed over 17,000 canine and feline lymphoma tests. These collaborations help the company refine their predictive models and improve their service offerings. The clinical evidence collected is a valuable resource in enhancing the accuracy of their drug response predictions.
Accreditations and Quality
ImpriMed's laboratory is accredited by A2LA for Canine Lymphoma/Leukemia Clonality Testing by PCR for Antigen Receptor Rearrangements (PARR) and Immunophenotyping by Flow Cytometry. The company is committed to providing high-quality and reliable services, reflected in their high customer satisfaction rate of 96%. They offer competitive pricing without compromising on quality and ensure fast turnaround times, typically within 3-7 days after receipt of the sample.
Educational Resources and Outreach
ImpriMed provides educational resources and guides for pet parents on topics such as canine and feline lymphoma, chemotherapy protocols, and treatment options. The company also offers a Veterinary Cancer Pioneers Podcast hosted by Dr. Rachel Venable, featuring discussions on advancements in veterinary oncology. Additionally, ImpriMed participates in various veterinary and medical conferences and events to showcase their research and advancements.